Ten years pharmacovigilance activities in Iran

Iranian Journal of Public Health

Volumn 38, Issue SUPPL. 1, 2009, Pages 162-165

  Shalviri, G ^a   Valadkhani, M ^a   Dinarvand, R ^a,b  

^a MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 69749086479     PISSN: 22516085     EISSN: 22516093     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Martyrs C (1979). Adverse reactions to drugs in general practice. BMJ, 2: 1194-97.
2. Imbs JL, Pouyanne P, Haramburu F, Welsch M, Decker N, Blayac JP, et al. (1999).Iatrogénie médicamenteuse: estimation de sa prévalence dans les hôpitaux publics français. Therapie, 54:21-7.
3. Bhalla N, Duggan C, Dhillon S (2003). The incidence and nature of drug-related admissions to hospital. Pharmaceutical Journal, 270 (7246): 583-86.
4. Blower AL, Brooks A, Fenn GC, Hill A, Pearce MY, Morant S, Bardhan KD (1997). Emergency admissions for upper gastrointestinal disease and their relation to NSAID use. Aliment Pharmacol Ther, 11: 283-91.
5. Lazarou J, Pomeranz BH, Corey PN (1998).Incidence of Adverse Drug Reactions in Hospitalized Patients. JAMA, 279: 1200-205.
6. Kohn LT, Corrigan JM, Donaldson MS (2000). To err is human: building a safer health system. 1st ed. National Academy Press. Washington, D.C.
7. Cohen MR (2007). Preventing medication errors: The Institute of Medicine report. AJHP, 64(14) Supplement 9:S1-S2.
8. Ernst FR, Grizzle AJ (2001). Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc,41(2): 192-9.
9. Fung M, Thornton A, Mybeck K, Wu J, Hornbuckle K, Muniz E (2001). Evaluation of the characteristics of safety with-drawal of prescription drugs from world-wide pharmaceutical markets-1960 to 1999. Drug Information Journal, 35:293-317.